ATE165345T1 - Sulfonsaeurederivate zur behandlung von viruserkrankungen - Google Patents

Sulfonsaeurederivate zur behandlung von viruserkrankungen

Info

Publication number
ATE165345T1
ATE165345T1 AT93903629T AT93903629T ATE165345T1 AT E165345 T1 ATE165345 T1 AT E165345T1 AT 93903629 T AT93903629 T AT 93903629T AT 93903629 T AT93903629 T AT 93903629T AT E165345 T1 ATE165345 T1 AT E165345T1
Authority
AT
Austria
Prior art keywords
sulfonic acid
treatment
acid derivatives
virus diseases
virus
Prior art date
Application number
AT93903629T
Other languages
English (en)
Inventor
Alan D Cardin
Norton P Peet
Nelsen L Lentz
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE165345T1 publication Critical patent/ATE165345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/42—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/51—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/42—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/02—Monothiocarbonic acids; Derivatives thereof
    • C07C329/04—Esters of monothiocarbonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/12—Dithiocarbonic acids; Derivatives thereof
    • C07C329/14—Esters of dithiocarbonic acids
    • C07C329/20—Esters of dithiocarbonic acids having sulfur atoms of dithiocarbonic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/08—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/14—Dithiocarbamic acids; Derivatives thereof
    • C07C333/18—Esters of dithiocarbamic acids
    • C07C333/24—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to carbon atoms of six-membered aromatic rings
AT93903629T 1992-02-20 1993-01-22 Sulfonsaeurederivate zur behandlung von viruserkrankungen ATE165345T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83863992A 1992-02-20 1992-02-20

Publications (1)

Publication Number Publication Date
ATE165345T1 true ATE165345T1 (de) 1998-05-15

Family

ID=25277670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93903629T ATE165345T1 (de) 1992-02-20 1993-01-22 Sulfonsaeurederivate zur behandlung von viruserkrankungen

Country Status (15)

Country Link
US (1) US5359131A (de)
EP (1) EP0626945B1 (de)
JP (1) JP3309104B2 (de)
KR (1) KR100275843B1 (de)
AT (1) ATE165345T1 (de)
AU (1) AU663925B2 (de)
CA (1) CA2130360C (de)
DE (1) DE69318136T2 (de)
ES (1) ES2115756T3 (de)
IL (1) IL104780A (de)
MX (1) MX9300836A (de)
NZ (1) NZ249032A (de)
TW (1) TW224968B (de)
WO (1) WO1993016992A1 (de)
ZA (1) ZA931035B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5670144A (en) * 1990-07-09 1997-09-23 Merrell Pharmaceuticals Inc. Anti-herpes virus and cytomegalovirus polyester oligomers
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
IL112174A (en) * 1994-01-03 1999-05-09 Merrell Dow Pharma Oligomers of polythioureas pharmaceutical compositions containing them and a process for their preparation
US5681832A (en) * 1995-02-17 1997-10-28 The United States Of America As Represented By The Department Of Health And Human Services Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity
EP0809492A4 (de) * 1995-02-17 2007-01-24 Smithkline Beecham Corp Il-8 rezeptor antagonisten
EE9800176A (et) * 1995-12-15 1998-12-15 Cryopreservation Technologies Cc Koostis organite külmsäilitamiseks ning viirus- ja bakterinfektsioonide ravimiseks
CN1163401A (zh) * 1996-02-13 1997-10-29 李占元 全自动血球计数仪试剂及配制方法
US5852015A (en) * 1997-01-27 1998-12-22 American Cyanamid Company Triazine containing anionic compounds useful as antiviral agents
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
HUP9903922A3 (en) 1996-06-27 2001-12-28 Smithkline Beecham Corp Il-8 receptor antagonists
KR20000022274A (ko) * 1996-06-27 2000-04-25 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Il-8 수용체 길항제
ZA984649B (en) * 1997-06-13 1999-12-17 Cryopreservation Tech Cc "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
GB9928418D0 (en) * 1999-12-01 2000-01-26 Novartis Ag Organic compounds
US6806366B2 (en) * 2001-02-02 2004-10-19 Wyeth Preparation and purification of antiviral disulfonic acid disodium salt
WO2005074919A1 (en) * 2004-02-04 2005-08-18 Active Biotech Ab Diurea derivatives
BRPI0713792A8 (pt) * 2006-06-27 2018-01-09 Hadasit Medical Res Services And Development Limited uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos
EP2117601A2 (de) * 2006-12-22 2009-11-18 The Regents of the University of California Makromolekulare konjugate von zystische-fibrose-transmembran-leitwert-regulatorprotein-inhibitoren und verwendungen davon
WO2010148177A2 (en) * 2009-06-17 2010-12-23 The Board Of Trustees Of The Leland Stanford Junior University Compounds, compositions, methods of synthesis, and methods of treatment
TW201702218A (zh) * 2014-12-12 2017-01-16 美國杰克森實驗室 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法
EP3883922A1 (de) * 2018-11-22 2021-09-29 Université de Nantes Disulfonatstilbene zur verwendung bei der behandlung von proliferativen krankheiten

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD39717A (de) *
US2676982A (en) * 1951-06-08 1954-04-27 Gen Aniline & Film Corp Fluorescent agents
BE660945A (de) * 1964-03-12 1965-07-01
US4107202A (en) * 1977-03-28 1978-08-15 American Cyanamid Company Substituted 4,4'-biphenylylene bis(2-thioureylene)di-naphthalenetrisulfonic acids and salts thereof
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
DE3600046A1 (de) * 1985-08-13 1987-07-09 Barthell Eduard Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung
DE3528992A1 (de) * 1985-08-13 1987-02-26 Barthell Eduard Sulfonamidderivate, verfahren zu ihrer herstellung und verwendung
DE3530718A1 (de) * 1985-08-28 1987-03-12 Madaus & Co Dr Methylendioxyphenanthren- und -stilbenderivate, verfahren zur herstellung derselben und arzneimittel, die diese enthalten
EP0221021B1 (de) * 1985-10-16 1989-11-08 Ciba-Geigy Ag Bechamp-Reduktion von DNS zu DAS mit H2SO4 und Spuren von HOAc
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
ATE116637T1 (de) * 1991-02-05 1995-01-15 Merrell Dow Pharma Sulfonische stilbenderivate zur behandlung von viruserkrankungen.

Also Published As

Publication number Publication date
AU3481893A (en) 1993-09-13
US5359131A (en) 1994-10-25
AU663925B2 (en) 1995-10-26
IL104780A (en) 1998-10-30
DE69318136T2 (de) 1998-10-22
KR950700245A (ko) 1995-01-16
ZA931035B (en) 1993-09-17
JPH07504190A (ja) 1995-05-11
JP3309104B2 (ja) 2002-07-29
ES2115756T3 (es) 1998-07-01
WO1993016992A1 (en) 1993-09-02
IL104780A0 (en) 1993-06-10
KR100275843B1 (ko) 2000-12-15
NZ249032A (en) 1996-09-25
CA2130360C (en) 1998-06-09
EP0626945B1 (de) 1998-04-22
MX9300836A (es) 1993-09-01
DE69318136D1 (de) 1998-05-28
TW224968B (de) 1994-06-11
CA2130360A1 (en) 1993-08-21
EP0626945A1 (de) 1994-12-07

Similar Documents

Publication Publication Date Title
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
EA199901031A1 (ru) Производные бензимидазола
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE3776999D1 (de) Mittel zur vorbeugung gegen pflanzenviruskrankheiten.
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ES2159287T3 (es) Peptidos hemorreguladores.
NO954702L (no) Aryldannende medikamenter
NO901396L (no) Fytosanitaere preparater, deres fremstilling og deres anvendelse for behandling av kryptogame sykdommer.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ATE356144T1 (de) Regulatorische/entfaltende peptide von ezrin
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69231465D1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
DE3883754T2 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
DE343258T1 (de) Mittel zur prophylaxe und behandlung von viralen infektionskrankheiten.
ATE63457T1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.
ATE18132T1 (de) Pharmazeutische praeparate zur behandlung von nagelentzuendungen.
NO864476D0 (no) Fremgangsmaate for syrebehandling.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner